PNVL3 logo

Dimed S.A. Distribuidora de Medicamentos Stock Price

BOVESPA:PNVL3 Community·R$1.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

PNVL3 Share Price Performance

R$10.59
2.19 (26.07%)
R$18.60
Fair Value
R$10.59
2.19 (26.07%)
43.1% undervalued intrinsic discount
R$18.60
Fair Value
Price R$10.59
AnalystConsensusTarget R$18.60

PNVL3 Community Narratives

·
Fair Value R$18.6 43.1% undervalued intrinsic discount

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative

Trending Discussion

Updated Narratives

PNVL3 logo

PNVL3: 2026 Shareholder Meetings Will Support Confident Repricing Case

Fair Value: R$18.6 43.1% undervalued intrinsic discount
11 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record and good value.

0 Risks
5 Rewards

Dimed S.A. Distribuidora de Medicamentos Key Details

R$5.7b

Revenue

R$3.7b

Cost of Revenue

R$2.0b

Gross Profit

R$1.8b

Other Expenses

R$132.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.89
34.56%
2.32%
46.2%
View Full Analysis

About PNVL3

Founded
1920
Employees
11282
CEO
Julio Mottin Neto
WebsiteView website
www.grupopanvel.com.br

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.

Recent PNVL3 News & Updates

Narrative Update Jun 04

PNVL3: 2026 Shareholder Meetings Will Support Confident Repricing Case

Analysts have trimmed their price target on Dimed Distribuidora de Medicamentos slightly from R$18.80 to R$18.60, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels. What's in the News Dimed Distribuidora de Medicamentos has scheduled a Special and Extraordinary Shareholders Meeting for April 30, 2026, at Avenida Industrial Belgraf 865, Eldorado do Sul, Rio Grande do Sul, Brazil.
Narrative Update May 01

PNVL3: Steady Fair Value Will Support Bullish Rerating Into 2026 Meeting

Analysts kept their fair value estimate for Dimed Distribuidora de Medicamentos steady at R$18.80, with a slightly higher discount rate and marginally adjusted revenue growth, profit margin, and future P/E inputs guiding the updated price target view. What's in the News Dimed S.A. Distribuidora de Medicamentos has scheduled a Special and Extraordinary Shareholders Meeting for April 30, 2026.

Recent updates

No updates